BetterLife Pharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Sep '24 Sep 24, 2024	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021	Jan '20 Jan 31, 2020	2019 - 2015
Market Capitalization	18	9	13	17	70	24	Upgrade
Market Cap Growth	147.49%	-35.00%	-23.05%	-75.11%	187.64%	7.90%	Upgrade
Enterprise Value	22	11	17	15	73	19	Upgrade
Last Close Price	0.13	0.09	0.15	0.20	1.36	0.14	Upgrade
PE Ratio	-	-3.40	-1.44	-1.27	-1.01	-0.10	Upgrade
PB Ratio	-2.50	-1.13	-1.77	-4.47	-15.11	9.12	Upgrade
P/FCF Ratio	-7.53	-3.51	-8.88	-1.55	-9.71	-2.88	Upgrade
P/OCF Ratio	-7.53	-3.51	-8.88	-1.55	-9.73	-3.08	Upgrade
EV/EBITDA Ratio	-	-3.47	-1.85	-1.56	-9.38	-2.32	Upgrade
EV/EBIT Ratio	-4.79	-3.45	-1.84	-1.55	-9.19	-2.08	Upgrade
EV/FCF Ratio	-9.17	-4.48	-11.35	-1.38	-10.19	-2.30	Upgrade
Debt / Equity Ratio	-0.14	-0.07	-0.03	-0.08	-0.11	1.77	Upgrade
Debt / FCF Ratio	-0.41	-0.23	-0.13	-0.03	-0.07	-0.56	Upgrade
Quick Ratio	0.02	0.01	0.00	0.12	0.12	2.94	Upgrade
Current Ratio	0.07	0.05	0.01	0.28	0.23	3.63	Upgrade
Return on Equity (ROE)	-	-	-	-	-	-636.82%	Upgrade
Return on Assets (ROA)	-707.53%	-1004.42%	-936.16%	-493.00%	-103.39%	-62.80%	Upgrade
Return on Capital (ROIC)	-	-	-	-	-306.26%	-72.35%	Upgrade
Earnings Yield	-32.37%	-33.29%	-67.53%	-70.08%	-52.15%	-80.83%	Upgrade
FCF Yield	-13.28%	-28.49%	-11.26%	-64.57%	-10.29%	-34.76%	Upgrade
Buyback Yield / Dilution	-20.64%	-26.25%	-14.70%	-179.24%	-79.75%	-66.69%	Upgrade
Total Shareholder Return	-20.64%	-26.25%	-14.70%	-179.24%	-79.75%	-66.69%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.